A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer Patients

Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Non-Small Cell Lung Cancer

NCT07150663 ·Status: RECRUITING ·Phase: PHASE3

Anlotinib in Advanced Solid Tumors With FGFR Alteration

NCT03929965 ·Status: UNKNOWN ·Phase: NA

Anlotinib Plus Penpulimab in Advanced Non-Small-Cell Lung Cancer Previously Treated With PD-1/PD-L1 Inhibitors

NCT05460481 ·Status: UNKNOWN ·Phase: PHASE2

A Prospective, Single-arm, Multicenter Exploratory Clinical Study of Anlotinib Combined With Bempegaldesleukin and Conventional Chemoradiotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Soft Tissue Sarcoma.

NCT07156643 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

NCT03975036 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3

Concurrent Chemoradiotherapy Combination With Anlotinib for Unresectable Stage III NSCLC Patients

NCT03672136 ·Status: UNKNOWN ·Phase: PHASE2

A Study of Anlotinib in Recurrent/Metastatic Head and Neck Adenocarcinomas

NCT03591666 ·Status: UNKNOWN ·Phase: PHASE2

The Clinical Trial to Evaluate the Pharmacokinetics and Safety of MRTX849 in Patients With Advanced Solid Tumors

NCT05263986 ·Status: UNKNOWN ·Phase: PHASE1

A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor

NCT04291248 ·Status: UNKNOWN ·Phase: PHASE2

Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT05807880 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Phase I Clinical Study of Metatinib Tromethamine Tablet

NCT02004548 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study of Anlotinib Combined With Chemotherapy in the Treatment of Unresectable Advanced Desmoid Tumor

NCT05490667 ·Status: UNKNOWN ·Phase: NA

SHR-1701 in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma

NCT04282070 ·Status: UNKNOWN ·Phase: PHASE1

Concurrent Chemoradiotherapy Combination With Anlotinib for Limited-stage Small Cell Lung Cancer

NCT04882033 ·Status: UNKNOWN ·Phase: PHASE1

To Evaluate the Efficacy and Safety of Anlotinib Hydrochloride Capsule in Postoperative Non-pCR Patients With Non-small Cell Lung Cancer

NCT06352008 ·Status: RECRUITING ·Phase: PHASE2

A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors

NCT06172309 ·Status: COMPLETED ·Phase: PHASE1

To Evaluate the Safety and Efficacy of TQB2858 Injection to the Subjects With Recurrent/Metastatic Nasopharyngeal Cancer

NCT05198531 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of CS23546 in Subjects With Advanced Tumors

NCT06245122 ·Status: RECRUITING ·Phase: PHASE1

A Study of XY0206 in Subjects With Advanced or Metastatic Solid Tumours

NCT03658070 ·Status: UNKNOWN ·Phase: PHASE1

A Single-arm Pilot Study of Tislelizumab Combined With Anlotinib in Patients With Advanced NSCLC With Driver-negative After Progression to Immunotherapy

NCT06356675 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Study of the AL3810 in the Treatment of Advanced Solid Tumor

NCT03117101 ·Status: COMPLETED ·Phase: PHASE1

Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung Cancer

NCT06341530 ·Status: RECRUITING ·Phase: PHASE2

Study of TQB2450 Combined With Anlotinib in the Treatment of Mutation Positive Lung Cancer

NCT03983928 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid Tumors

NCT05781360 ·Status: TERMINATED ·Phase: PHASE1

Chemoradiotherapy for Patients With Locally Advanced Nasopharyngeal Carcinoma Using Raltitrexed-Cisplatin

NCT02562599 ·Status: COMPLETED ·Phase: PHASE2